Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TAILORED-PROM in preterm premature rupture of membranes
2024-520237-77-00Phase 3Authorised
- Sponsor
- General University Hospital in Prague
- Start
- Jun 2025
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Implantable Devices → Device-based Delivery → Drug Delivery Systems, Transdermal Patches → Device-based Delivery → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 3, open-label trial of benzylpenicillin, magnesium sulfate, dexamethasone, gentamicin, ampicillin + sulbactam and 1 more in Preterm prelabor rupture of membranes (PPROM), sponsored by General University Hospital in Prague. Primary endpoint: Primary: pregnancy latency more than 7 days. Planned start Jun 2025; status: authorised.
02
Drugs
benzylpenicillinmagnesium sulfatedexamethasonegentamicinampicillin + sulbactam
03
Conditions
Preterm prelabor rupture of membranes (PPROM)
Beyond the preview
Go deeper on 2024-520237-77-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-520237-77-00.